IN2014CN02562A - - Google Patents
Info
- Publication number
- IN2014CN02562A IN2014CN02562A IN2562CHN2014A IN2014CN02562A IN 2014CN02562 A IN2014CN02562 A IN 2014CN02562A IN 2562CHN2014 A IN2562CHN2014 A IN 2562CHN2014A IN 2014CN02562 A IN2014CN02562 A IN 2014CN02562A
- Authority
- IN
- India
- Prior art keywords
- formula
- compound
- reaction
- preparation
- novel
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 abstract 2
- 229960000499 ulipristal acetate Drugs 0.000 abstract 2
- 239000007818 Grignard reagent Substances 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- -1 methyl Grignard reagent Chemical class 0.000 abstract 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 238000007086 side reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110339479.8A CN102516345B (zh) | 2011-11-01 | 2011-11-01 | 醋酸乌利司他及其关键中间体的制备方法 |
| PCT/CN2012/000952 WO2013063859A1 (zh) | 2011-11-01 | 2012-07-12 | 醋酸乌利司他的制备方法及其中间体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CN02562A true IN2014CN02562A (enrdf_load_stackoverflow) | 2015-08-07 |
Family
ID=46287461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2562CHN2014 IN2014CN02562A (enrdf_load_stackoverflow) | 2011-11-01 | 2012-07-12 |
Country Status (14)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102516345B (zh) * | 2011-11-01 | 2014-11-26 | 上海优拓医药科技有限公司 | 醋酸乌利司他及其关键中间体的制备方法 |
| CN103073612B (zh) * | 2013-02-04 | 2015-11-04 | 山东大学 | 醋酸乌利司他关键中间体的制备方法 |
| CN103145788B (zh) * | 2013-03-25 | 2015-08-19 | 浙江仙琚制药股份有限公司 | 醋酸优力司特关键中间体的制备方法 |
| HU230319B1 (hu) * | 2013-10-01 | 2016-01-28 | Richter Gedeon Nyrt. | Ipari eljárás szteroid hatóanyagok előállítására |
| CN104558089A (zh) * | 2013-10-25 | 2015-04-29 | 上海医药工业研究院 | 一种3-(亚乙二氧基)-17β-氰基-17α-羟基-雌-5(10)，9(11)-二烯的制备方法 |
| CN103641881A (zh) * | 2013-11-22 | 2014-03-19 | 湖南新合新生物医药有限公司 | 乌利司他中间体的制备方法 |
| CN103601785A (zh) * | 2013-11-25 | 2014-02-26 | 四川大学 | 一种醋酸优力斯特新的合成方法 |
| CN104774231A (zh) * | 2014-01-13 | 2015-07-15 | 上海医药工业研究院 | 17α-羟基-19-去甲孕甾-4,9-二烯-3,20-二酮的制备工艺 |
| CN105294808B (zh) * | 2015-09-28 | 2017-08-25 | 国家卫生计生委科学技术研究所 | 醋酸乌利司他晶g型物质及制备方法和其组合物与用途 |
| CN105237607B (zh) * | 2015-10-29 | 2018-10-02 | 国家卫生计生委科学技术研究所 | 醋酸乌利司他晶k型物质及制备方法和其组合物与用途 |
| CN105566432B (zh) * | 2016-02-19 | 2017-11-03 | 常州四药制药有限公司 | 一种醋酸乌利司他的杂质及其制备和检测方法 |
| CN105566431B (zh) * | 2016-02-19 | 2017-11-24 | 常州市第四制药厂有限公司 | 一种醋酸乌利司他的杂质及其制备和检测方法 |
| CN105669810B (zh) * | 2016-02-19 | 2017-05-10 | 常州市第四制药厂有限公司 | 一种醋酸乌利司他的杂质及其制备和检测方法 |
| CN105669819B (zh) * | 2016-03-23 | 2017-06-23 | 浙江仙琚制药股份有限公司 | 制备醋酸优力司特双缩酮异构体的方法 |
| CN106866778A (zh) * | 2017-04-25 | 2017-06-20 | 广西万德药业有限公司 | 一种5(10)位α环氧甾族化合物的合成方法 |
| CN108070016B (zh) * | 2017-12-29 | 2020-07-07 | 广西万德药业有限公司 | 甾体环氧异构体的循环利用方法 |
| CN108558981B (zh) * | 2018-05-08 | 2020-05-08 | 浙江仙琚制药股份有限公司 | 制备双缩酮的方法 |
| JP7303618B2 (ja) * | 2018-10-05 | 2023-07-05 | 日本精化株式会社 | スフィンゴリン脂質前駆体及びその製造方法、並びに、スフィンゴリン脂質の製造方法 |
| CN110256519B (zh) * | 2019-05-23 | 2021-06-08 | 江苏联环药业股份有限公司 | 一锅法制备醋酸乌利司他的方法 |
| CN111018935A (zh) * | 2019-12-31 | 2020-04-17 | 浙江仙居君业药业有限公司 | 一种醋酸乌利斯他中间体的合成方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ222103A (en) * | 1986-10-10 | 1990-08-28 | Gist Brocades Nv | 9-alpha-hydroxy steroids and pharmaceutical preparations containing them |
| US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
| US5929262A (en) * | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
| US6020328A (en) * | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| ES2546291T3 (es) | 2000-03-17 | 2015-09-22 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | 17-Alfa-sustituida, 11-beta-sustituida-4-arilo y 21-sustituida 19-norpregnadienodionas como agentes antiprogestacionales |
| AU2004217988C1 (en) * | 2003-02-28 | 2010-06-03 | Southwest Foundation For Biomedical Research | Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
| US20050288521A1 (en) * | 2004-06-29 | 2005-12-29 | Phytogen Life Sciences Inc. | Semi-synthetic conversion of paclitaxel to docetaxel |
| HU227112B1 (hu) * | 2006-06-14 | 2010-07-28 | Richter Gedeon Nyrt | Ipari eljárás 17-alfa-acetoxi-11-béta-[4-(N,N-dimetil-amino)-fenil]-19-norpregna-4,9-dién-3,20-dion elõállítására és új intermedierek az eljáráshoz |
| HU228636B1 (en) * | 2007-06-27 | 2013-04-29 | Richter Gedeon Nyrt | Industrial method for the synthesis of 17-acetoxy-11betha-4[-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process |
| CN102516345B (zh) * | 2011-11-01 | 2014-11-26 | 上海优拓医药科技有限公司 | 醋酸乌利司他及其关键中间体的制备方法 |
-
2011
- 2011-11-01 CN CN201110339479.8A patent/CN102516345B/zh active Active
-
2012
- 2012-07-12 MX MX2014005245A patent/MX343774B/es active IP Right Grant
- 2012-07-12 BR BR112014010263-5A patent/BR112014010263B1/pt not_active IP Right Cessation
- 2012-07-12 JP JP2014534915A patent/JP5913599B2/ja active Active
- 2012-07-12 IN IN2562CHN2014 patent/IN2014CN02562A/en unknown
- 2012-07-12 WO PCT/CN2012/000952 patent/WO2013063859A1/zh active Application Filing
- 2012-07-12 CA CA2851399A patent/CA2851399C/en active Active
- 2012-07-12 EP EP12845071.5A patent/EP2774933B1/en active Active
- 2012-07-12 PL PL12845071T patent/PL2774933T3/pl unknown
- 2012-07-12 HU HUE12845071A patent/HUE037674T2/hu unknown
- 2012-07-12 US US14/233,757 patent/US9163058B2/en active Active
- 2012-07-12 AU AU2012331996A patent/AU2012331996B2/en active Active
- 2012-07-12 ES ES12845071.5T patent/ES2669052T3/es active Active
- 2012-07-12 RU RU2014120908A patent/RU2624007C2/ru active IP Right Revival
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014528459A (ja) | 2014-10-27 |
| US20140296510A1 (en) | 2014-10-02 |
| CN102516345A (zh) | 2012-06-27 |
| MX2014005245A (es) | 2014-08-22 |
| CN102516345B (zh) | 2014-11-26 |
| PL2774933T3 (pl) | 2018-08-31 |
| WO2013063859A1 (zh) | 2013-05-10 |
| CA2851399C (en) | 2019-06-25 |
| ES2669052T3 (es) | 2018-05-23 |
| CA2851399A1 (en) | 2013-05-10 |
| EP2774933B1 (en) | 2018-02-21 |
| BR112014010263B1 (pt) | 2021-11-03 |
| MX343774B (es) | 2016-11-23 |
| HUE037674T2 (hu) | 2018-09-28 |
| AU2012331996B2 (en) | 2015-04-23 |
| EP2774933A4 (en) | 2015-07-08 |
| US9163058B2 (en) | 2015-10-20 |
| RU2014120908A (ru) | 2015-12-10 |
| JP5913599B2 (ja) | 2016-04-27 |
| AU2012331996A1 (en) | 2014-05-15 |
| RU2624007C2 (ru) | 2017-06-30 |
| EP2774933A1 (en) | 2014-09-10 |
| BR112014010263A2 (pt) | 2017-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014CN02562A (enrdf_load_stackoverflow) | ||
| AU2012267929A8 (en) | Synthetic formulations and methods of manufacturing and using thereof | |
| EP3598899A3 (en) | Plant growth-promoting microbes and uses therefor | |
| UA97619C2 (ru) | Гидрогалогенидный комплекс агомелатина и способ его получения | |
| PH12015500211A1 (en) | 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes | |
| WO2014041559A3 (en) | Process for preparation of dabigatran etexilate and intermediates thereof | |
| MY160460A (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| NZ595591A (en) | Processes for the preparation of morphinane and morphinone compounds | |
| WO2009134531A3 (en) | Total synthesis of salinosporamide a and analogs thereof | |
| TN2012000435A1 (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| TR201903978T4 (tr) | L-ornitin fenil asetat yapım yöntemleri. | |
| PH12012501438A1 (en) | Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same | |
| PH12013501859A1 (en) | Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides | |
| WO2012031045A3 (en) | Phosphonate ester derivatives and methods of synthesis thereof | |
| MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
| IN2014DN02166A (enrdf_load_stackoverflow) | ||
| TN2012000436A1 (en) | Agomelatine hydrobromide hydrate and preparation thereof | |
| MX353863B (es) | Metodo para preparar una forma solida de acido acetico y productos de la misma. | |
| WO2013190455A3 (en) | Process for the preparation of lurasidone hydrochloride | |
| MY164880A (en) | Process for the preparation of isoxazolyl-methoxy-nicotinic acids | |
| WO2012115402A3 (en) | Crystalline form of docetaxel and process for preparation thereof | |
| WO2013096976A3 (en) | Process conditions for producing acrylic acid | |
| WO2013046233A3 (en) | Process for the preparation of octreotide acetate | |
| WO2011098439A3 (en) | A process for introducing a double bond into position 15,16 of a steroid | |
| WO2012052939A3 (en) | Preparation of bicyclo[2.2.2]octan-2-one compounds |